Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

被引：0
|
作者：
Xiaoying Gu
Su Zhang
Xuejiao Yang
Tao Guan
Zhenyu Hou
Manqing Cao
Huikai Li
Ti Zhang
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Hepatobiliary Surgery, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy
[2] National Clinical Research Center for Cancer,Department of Gynecologic Oncology, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy
[3] Tianjin Medical University Cancer Institute and Hospital,Present Address: Department of Anesthesiology
[4] National Clinical Research Center for Cancer,Department of Breast Surgery, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy
[5] The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture,Present Address: Department of Hepatic Surgery
[6] Tianjin Medical University Cancer Institute and Hospital,undefined
[7] National Clinical Research Center for Cancer,undefined
[8] Fudan University Shanghai Cancer Center,undefined
[9] Shanghai Medical College,undefined
[10] Fudan University,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
Apatinib; Anti-angiogenesis therapy; Adverse Events; Hepatocellular Carcinoma; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
    Gu, Xiaoying
    Zhang, Su
    Yang, Xuejiao
    Guan, Tao
    Hou, Zhenyu
    Cao, Manqing
    Li, Huikai
    Zhang, Ti
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [2] Drug-Related Adverse Events May Predict Efficacy in Sorafenib Therapy for Hepatocellular Carcinoma
    Zhao, Yan
    Yang, Man
    Qi, Xingshun
    Han, Guohong
    Fan, Daiming
    HEPATOLOGY, 2012, 56 (02)
  • [3] Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma
    Yang, XueJiao
    Hou, ZhenYu
    Zhu, KeYun
    Zhang, Su
    Gu, XiaoYing
    Wang, ZhiWei
    Mu, Han
    Zhou, HongYuan
    Chen, Ping
    Zhu, XiaoLin
    Cui, YunLong
    Li, Qiang
    Li, HuiKai
    Zhang, Ti
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3163 - 3173
  • [4] Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma (vol 12, pg 3163, 2020)
    Yang, X.
    Hou, Z.
    Zhu, K.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4169 - 4170
  • [5] Polypharmacy and adverse drug-related events
    Everett, WW
    ANNALS OF EMERGENCY MEDICINE, 2003, 41 (02) : 278 - 279
  • [6] Polypharmacy and adverse drug-related events - In reply
    Hohl, CM
    ANNALS OF EMERGENCY MEDICINE, 2003, 41 (02) : 279 - 279
  • [7] Drug-Related Adverse Events of Osteoporosis Therapy
    Khan, Moira
    Cheung, Angela M.
    Khan, Aliya A.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2017, 46 (01) : 181 - +
  • [8] DRUG-RELATED ADVERSE EVENTS IN HOSPITALIZED ADULTS
    BATES, DW
    LEAPE, L
    PETRYCKI, S
    CLINICAL RESEARCH, 1991, 39 (02): : A596 - A596
  • [9] Counting the Costs of Drug-Related Adverse Events
    T. Jeffrey White
    Annet Arakelian
    Jay P. Rho
    PharmacoEconomics, 1999, 15 : 445 - 458
  • [10] Counting the costs of drug-related adverse events
    White, TJ
    Arakelian, A
    Rho, JP
    PHARMACOECONOMICS, 1999, 15 (05) : 445 - 458
12345